Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, USA.
Department of Neurology, University of Washington, Seattle, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.
J Neurol Sci. 2023 Sep 15;452:120763. doi: 10.1016/j.jns.2023.120763. Epub 2023 Aug 7.
NOTCH3 is the causative gene for autosomal dominant cerebral arteriopathy with subcortical infarctions and leukoencephalopathy (CADASIL) which is associated with both stroke and dementia. When CADASIL presents primarily as dementia it can be difficult to distinguish from Alzheimer's disease (AD) at both the clinical and neuropathological levels.
We performed exome sequencing of several affected individuals from a large family affected with AD. PCR amplification and direct Sanger sequencing were used to verify variants detected by exome analysis and to screen family members at-risk to carry those variants. Neuropathologic brain evaluation by immunohistochemistry and MRI were performed for the carriers of the NOTCH3 variant.
In a three-generation family with AD, we found a c.601 T > C p.Cys201Arg variant in the NOTCH3 gene that caused clinical and neuropathological manifestations of CADASIL. These features included earlier onset of dementia accompanied by behavioral abnormalities in the father and son and white matter abnormalities in the asymptomatic grandson. The family is one branch of a large pedigree studied by the Alzheimer's Disease Sequencing Project (ADSP). As part of the ADSP linkage analysis and whole genome sequencing endeavor, an ABCA1 variant, p.Ala937Val, was previously found associated with AD in this pedigree.
Our findings, together with other reported pathogenic missense variants of the C201 codon in NOTCH3, support the role of cysteine 201 as a mutation hotspot for CADASIL and highlight the genetic complexity both clinically and pathologically of AD and related dementia.
NOTCH3 是常染色体显性脑动脉病伴皮质下梗死和白质脑病(CADASIL)的致病基因,该病与中风和痴呆有关。当 CADASIL 主要表现为痴呆时,在临床和神经病理学水平上很难与阿尔茨海默病(AD)区分。
我们对一个受 AD 影响的大家庭中的几个受影响个体进行了外显子组测序。PCR 扩增和直接 Sanger 测序用于验证外显子分析检测到的变体,并筛选有携带这些变体风险的家庭成员。对携带 NOTCH3 变异体的携带者进行免疫组织化学和 MRI 神经病理学脑评估。
在一个有 AD 的三代家族中,我们发现 NOTCH3 基因中的 c.601T>C p.Cys201Arg 变体导致 CADASIL 的临床和神经病理学表现。这些特征包括父亲和儿子痴呆症发病更早,伴有行为异常,无症状的孙子有白质异常。该家族是阿尔茨海默病测序计划(ADSP)研究的一个大型家系的一个分支。作为 ADSP 连锁分析和全基因组测序工作的一部分,先前在该家系中发现了 ABCA1 变体 p.Ala937Val 与 AD 相关。
我们的发现,连同其他报道的 NOTCH3 中 C201 密码子的致病性错义变体一起,支持半胱氨酸 201 作为 CADASIL 的突变热点的作用,并强调了 AD 及相关痴呆症在临床上和病理学上的遗传复杂性。